Shanghai Yizhong Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Yizhong Pharmaceutical has a total shareholder equity of CN¥1.4B and total debt of CN¥10.9M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥1.5B and CN¥50.9M respectively. Shanghai Yizhong Pharmaceutical's EBIT is CN¥48.8M making its interest coverage ratio -1.6. It has cash and short-term investments of CN¥654.1M.
Key information
0.8%
Debt to equity ratio
CN¥10.91m
Debt
| Interest coverage ratio | -1.6x |
| Cash | CN¥654.14m |
| Equity | CN¥1.44b |
| Total liabilities | CN¥50.90m |
| Total assets | CN¥1.49b |
Recent financial health updates
Recent updates
Subdued Growth No Barrier To Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) With Shares Advancing 27%
Nov 20
We Think You Can Look Beyond Shanghai Yizhong Pharmaceutical's (SHSE:688091) Lackluster Earnings
Nov 08There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump
Oct 01Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?
Aug 20What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You
Jul 24Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance
Apr 15Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely
Mar 29Financial Position Analysis
Short Term Liabilities: 688091's short term assets (CN¥845.8M) exceed its short term liabilities (CN¥47.0M).
Long Term Liabilities: 688091's short term assets (CN¥845.8M) exceed its long term liabilities (CN¥3.9M).
Debt to Equity History and Analysis
Debt Level: 688091 has more cash than its total debt.
Reducing Debt: 688091's debt to equity ratio has increased from 0% to 0.8% over the past 5 years.
Debt Coverage: 688091's debt is well covered by operating cash flow (409.8%).
Interest Coverage: 688091 earns more interest than it pays, so coverage of interest payments is not a concern.